Literature DB >> 7972030

The palmitoylated cysteine of the cytoplasmic tail of alpha 2A-adrenergic receptors confers subtype-specific agonist-promoted downregulation.

M G Eason1, M T Jacinto, C T Theiss, S B Liggett.   

Abstract

Most guanine nucleotide binding protein (G protein)-coupled receptors have a conserved cysteine in the C-terminal cytoplasmic tail near the seventh transmembrane spanning region. This cysteine is known to be palmitoylated in rhodopsin, the beta 2-adrenergic receptor (beta 2AR) and the alpha 2A-adrenergic receptor (alpha 2AAR). For the beta 2AR, this cysteine has been shown to be important for stimulatory G protein (Gs) coupling and agonist-promoted desensitization. For the alpha 2AAR (human alpha 2 C10) palmitoylation occurs at Cys-442, but it is not known what function such fatty acid acylation subserves. The closely related alpha 2CAR subtype denoted alpha 2C4 lacks a cysteine in this region and has different G-protein-coupling characteristics and agonist regulatory properties as compared to alpha 2C10. To assess the role of the palmitoylcysteine in alpha 2AR function, we constructed a mutated alpha 2C10 having a phenylalanine (the analogous amino acid in the alpha 2C4 in this position) substituted for Cys-442, denoted alpha 2C10(Phe-442), and expressed this along with wild-type alpha 2C10 and alpha 2C4 in CHO cells. Functional coupling to inhibitory G protein (Gi) and to Gs was identical between wild-type alpha 2C10 and alpha 2C10(Phe-442). Agonist-promoted desensitization of both the Gi and Gs-mediated pathways was also found to be unaffected by this mutation. Cellular trafficking induced by agonist exposure was evaluated by delineation of intracellular (sequestered) versus cell surface receptors and by determination of net receptor loss. Mutation of Cys-442 did not alter the extent or rate of agonist-promoted sequestration induced by agonists or the recovery from sequestration. However, the downregulation of receptor number after prolonged agonist exposure was completely abolished by this mutation and converted alpha 2C10 to an alpha 2C4 phenotype in regard to this adaptive response. Another mutated alpha 2C10, in which Cys-442 was replaced by alanine, also failed to downregulate. Thus, the function of this cytoplasmic palmitoylcysteine is distinctly different between the alpha 2AR and other G-protein-coupled receptors such as the beta 2AR and rhodopsin, and this suggests that this molecular attribute may subserve diverse roles among members of this family of receptors. For the alpha 2ARs, this may represent an evolved feature that provides for differing needs for regulation of the alpha 2C10 and alpha 2C4 subtypes by agonist.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7972030      PMCID: PMC45190          DOI: 10.1073/pnas.91.23.11178

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Simultaneous coupling of alpha 2-adrenergic receptors to two G-proteins with opposing effects. Subtype-selective coupling of alpha 2C10, alpha 2C4, and alpha 2C2 adrenergic receptors to Gi and Gs.

Authors:  M G Eason; H Kurose; B D Holt; J R Raymond; S B Liggett
Journal:  J Biol Chem       Date:  1992-08-05       Impact factor: 5.157

2.  Subtype-selective desensitization of alpha 2-adrenergic receptors. Different mechanisms control short and long term agonist-promoted desensitization of alpha 2C10, alpha 2C4, and alpha 2C2.

Authors:  M G Eason; S B Liggett
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

3.  Distinct pathways of desensitization of A1- and A2-adenosine receptors in DDT1 MF-2 cells.

Authors:  V Ramkumar; M E Olah; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1991-11       Impact factor: 4.436

4.  Selective amplification and cloning of four new members of the G protein-coupled receptor family.

Authors:  F Libert; M Parmentier; A Lefort; C Dinsart; J Van Sande; C Maenhaut; M J Simons; J E Dumont; G Vassart
Journal:  Science       Date:  1989-05-05       Impact factor: 47.728

5.  Depalmitylation with hydroxylamine alters the functional properties of rhodopsin.

Authors:  D F Morrison; P J O'Brien; D R Pepperberg
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

6.  Sites in the third intracellular loop of the alpha 2A-adrenergic receptor confer short term agonist-promoted desensitization. Evidence for a receptor kinase-mediated mechanism.

Authors:  S B Liggett; J Ostrowski; L C Chesnut; H Kurose; J R Raymond; M G Caron; R J Lefkowitz
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

Review 7.  Sequence alignment of the G-protein coupled receptor superfamily.

Authors:  W C Probst; L A Snyder; D I Schuster; J Brosius; S C Sealfon
Journal:  DNA Cell Biol       Date:  1992 Jan-Feb       Impact factor: 3.311

8.  Subtype-specific differences in the intracellular sorting of G protein-coupled receptors.

Authors:  M von Zastrow; R Link; D Daunt; G Barsh; B Kobilka
Journal:  J Biol Chem       Date:  1993-01-15       Impact factor: 5.157

9.  Hormonal stimulation of adenylyl cyclase through Gi-protein beta gamma subunits.

Authors:  A D Federman; B R Conklin; K A Schrader; R R Reed; H R Bourne
Journal:  Nature       Date:  1992-03-12       Impact factor: 49.962

10.  Altered phosphorylation and desensitization patterns of a human beta 2-adrenergic receptor lacking the palmitoylated Cys341.

Authors:  S Moffett; B Mouillac; H Bonin; M Bouvier
Journal:  EMBO J       Date:  1993-01       Impact factor: 11.598

View more
  19 in total

1.  Palmitoylation of the recombinant human A1 adenosine receptor: enhanced proteolysis of palmitoylation-deficient mutant receptors.

Authors:  Z Gao; Y Ni; G Szabo; J Linden
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

Review 2.  Structural features of heterotrimeric G-protein-coupled receptors and their modulatory proteins.

Authors:  H LeVine
Journal:  Mol Neurobiol       Date:  1999-04       Impact factor: 5.590

3.  5-Hydroxytryptamine 4(a) receptor expressed in Sf9 cells is palmitoylated in an agonist-dependent manner.

Authors:  E G Ponimaskin; M F Schmidt; M Heine; U Bickmeyer; D W Richter
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

4.  Structural insight into the role of the human melanocortin 3 receptor cysteine residues on receptor function.

Authors:  Yingkui Yang; Min Chen; David McPherson; Vinod Mishra; Carroll M Harmon
Journal:  Peptides       Date:  2011-10-31       Impact factor: 3.750

5.  Regulation of alpha2AR trafficking and signaling by interacting proteins.

Authors:  Qin Wang; Lee E Limbird
Journal:  Biochem Pharmacol       Date:  2006-12-28       Impact factor: 5.858

6.  Pseudo-enzymatic S-acylation of a myristoylated yes protein tyrosine kinase peptide in vitro may reflect non-enzymatic S-acylation in vivo.

Authors:  M C Bañó; C S Jackson; A I Magee
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

Review 7.  Regulatory mechanisms that modulate signalling by G-protein-coupled receptors.

Authors:  S K Böhm; E F Grady; N W Bunnett
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

8.  Involvement of the first transmembrane segment of human α(2) -adrenoceptors in the subtype-selective binding of chlorpromazine, spiperone and spiroxatrine.

Authors:  J M M Laurila; G Wissel; H Xhaard; J O Ruuskanen; M S Johnson; M Scheinin
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

9.  Cytoplasmic tail length influences fatty acid selection for acylation of viral glycoproteins.

Authors:  M Veit; H Reverey; M F Schmidt
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

10.  Control of signalling efficacy by palmitoylation of the rat Y1 receptor.

Authors:  Nicholas D Holliday; Helen M Cox
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.